New Analysis Supports Paxlovid Use
- Aryaman Sinha
- Sep 23, 2022
- 1 min read

Here's one more data point to consider in the back-and-forth about Pfizer's antiviral pill Paxlovid: A new analysis found it can meaningfully reduce COVID hospitalizations and deaths, even in those younger than 65. WOW!
Photo Credit: MARK ADRIANE
Comments